Annual Operating Profit
-$268.13 M
-$5.25 M-2.00%
31 December 2023
Summary:
REGENXBIO annual operaing income is currently -$268.13 million, with the most recent change of -$5.25 million (-2.00%) on 31 December 2023. During the last 3 years, it has fallen by -$148.90 million (-124.88%). RGNX annual operating profit is now -267.60% below its all-time high of $159.98 million, reached on 31 December 2021.RGNX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$62.08 M
-$6.04 M-10.78%
30 September 2024
Summary:
REGENXBIO quarterly operating income is currently -$62.08 million, with the most recent change of -$6.04 million (-10.78%) on 30 September 2024. Over the past year, it has increased by +$2.88 million (+4.44%). RGNX quarterly operating profit is now -119.80% below its all-time high of $313.60 million, reached on 31 December 2021.RGNX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$243.78 M
+$2.88 M+1.17%
30 September 2024
Summary:
REGENXBIO TTM operating income is currently -$243.78 million, with the most recent change of +$2.88 million (+1.17%) on 30 September 2024. Over the past year, it has increased by +$18.22 million (+6.95%). RGNX TTM operating profit is now -252.38% below its all-time high of $159.98 million, reached on 31 December 2021.RGNX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.0% | +4.4% | +7.0% |
| 3 y3 years | -124.9% | -8.3% | -17.6% |
| 5 y5 years | -404.4% | -72.9% | -129.5% |
RGNX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -267.6% | at low | -119.8% | +15.1% | -252.4% | +9.1% |
| 5 y | 5 years | -267.6% | at low | -119.8% | +15.1% | -252.4% | +9.1% |
| alltime | all time | -267.6% | at low | -119.8% | +15.1% | -252.4% | +9.1% |
REGENXBIO Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$62.08 M(+10.8%) | -$243.78 M(-1.2%) |
| June 2024 | - | -$56.04 M(-9.3%) | -$246.66 M(-6.5%) |
| Mar 2024 | - | -$61.76 M(-3.4%) | -$263.73 M(-1.6%) |
| Dec 2023 | -$268.13 M(+2.0%) | -$63.90 M(-1.6%) | -$268.13 M(+2.3%) |
| Sept 2023 | - | -$64.96 M(-11.1%) | -$262.00 M(-2.3%) |
| June 2023 | - | -$73.11 M(+10.5%) | -$268.08 M(+4.1%) |
| Mar 2023 | - | -$66.16 M(+14.5%) | -$257.51 M(-2.0%) |
| Dec 2022 | -$262.88 M(-264.3%) | -$57.77 M(-18.7%) | -$262.88 M(-342.3%) |
| Sept 2022 | - | -$71.05 M(+13.6%) | $108.49 M(-11.2%) |
| June 2022 | - | -$62.53 M(-12.6%) | $122.19 M(-7.8%) |
| Mar 2022 | - | -$71.53 M(-122.8%) | $132.50 M(-17.2%) |
| Dec 2021 | $159.98 M(-234.2%) | $313.60 M(-646.8%) | $159.98 M(-177.2%) |
| Sept 2021 | - | -$57.35 M(+9.8%) | -$207.27 M(+52.4%) |
| June 2021 | - | -$52.23 M(+18.6%) | -$135.97 M(+8.3%) |
| Mar 2021 | - | -$44.04 M(-17.9%) | -$125.58 M(+5.3%) |
| Dec 2020 | -$119.23 M(-20.0%) | -$53.65 M(-484.6%) | -$119.23 M(+12.6%) |
| Sept 2020 | - | $13.95 M(-133.3%) | -$105.91 M(-32.0%) |
| June 2020 | - | -$41.83 M(+11.0%) | -$155.75 M(+3.3%) |
| Mar 2020 | - | -$37.70 M(-6.5%) | -$150.79 M(+1.2%) |
| Dec 2019 | -$149.00 M | -$40.32 M(+12.3%) | -$149.00 M(+40.3%) |
| Sept 2019 | - | -$35.90 M(-2.6%) | -$106.22 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$36.87 M(+2.7%) | -$93.05 M(+86.7%) |
| Mar 2019 | - | -$35.91 M(-1565.6%) | -$49.83 M(-156.6%) |
| Dec 2018 | $88.10 M(-216.1%) | $2.45 M(-110.8%) | $88.10 M(+27.6%) |
| Sept 2018 | - | -$22.73 M(-457.9%) | $69.05 M(-2.0%) |
| June 2018 | - | $6.35 M(-93.8%) | $70.47 M(+43.6%) |
| Mar 2018 | - | $102.03 M(-714.7%) | $49.06 M(-164.7%) |
| Dec 2017 | -$75.89 M(+16.1%) | -$16.60 M(-22.1%) | -$75.89 M(-4.9%) |
| Sept 2017 | - | -$21.31 M(+41.5%) | -$79.76 M(+3.4%) |
| June 2017 | - | -$15.06 M(-34.3%) | -$77.11 M(+0.1%) |
| Mar 2017 | - | -$22.92 M(+12.0%) | -$77.01 M(+17.9%) |
| Dec 2016 | -$65.34 M(+182.4%) | -$20.47 M(+9.6%) | -$65.34 M(+29.7%) |
| Sept 2016 | - | -$18.67 M(+24.9%) | -$50.37 M(+29.0%) |
| June 2016 | - | -$14.95 M(+32.9%) | -$39.05 M(+28.5%) |
| Mar 2016 | - | -$11.25 M(+104.6%) | -$30.39 M(+31.4%) |
| Dec 2015 | -$23.14 M(+528.4%) | -$5.50 M(-25.2%) | -$23.14 M(+16.5%) |
| Sept 2015 | - | -$7.35 M(+16.7%) | -$19.86 M(+40.0%) |
| June 2015 | - | -$6.30 M(+57.7%) | -$14.19 M(+79.7%) |
| Mar 2015 | - | -$3.99 M(+79.1%) | -$7.90 M(+102.3%) |
| Dec 2014 | -$3.68 M(-22.7%) | -$2.23 M(+33.0%) | -$3.90 M(+133.0%) |
| Sept 2014 | - | -$1.68 M | -$1.68 M |
| Dec 2013 | -$4.76 M | - | - |
FAQ
- What is REGENXBIO annual operaing income?
- What is the all time high annual operating profit for REGENXBIO?
- What is REGENXBIO annual operating profit year-on-year change?
- What is REGENXBIO quarterly operating income?
- What is the all time high quarterly operating profit for REGENXBIO?
- What is REGENXBIO quarterly operating profit year-on-year change?
- What is REGENXBIO TTM operating income?
- What is the all time high TTM operating profit for REGENXBIO?
- What is REGENXBIO TTM operating profit year-on-year change?
What is REGENXBIO annual operaing income?
The current annual operating profit of RGNX is -$268.13 M
What is the all time high annual operating profit for REGENXBIO?
REGENXBIO all-time high annual operaing income is $159.98 M
What is REGENXBIO annual operating profit year-on-year change?
Over the past year, RGNX annual operaing income has changed by -$5.25 M (-2.00%)
What is REGENXBIO quarterly operating income?
The current quarterly operating profit of RGNX is -$62.08 M
What is the all time high quarterly operating profit for REGENXBIO?
REGENXBIO all-time high quarterly operating income is $313.60 M
What is REGENXBIO quarterly operating profit year-on-year change?
Over the past year, RGNX quarterly operating income has changed by +$2.88 M (+4.44%)
What is REGENXBIO TTM operating income?
The current TTM operating profit of RGNX is -$243.78 M
What is the all time high TTM operating profit for REGENXBIO?
REGENXBIO all-time high TTM operating income is $159.98 M
What is REGENXBIO TTM operating profit year-on-year change?
Over the past year, RGNX TTM operating income has changed by +$18.22 M (+6.95%)